Sclerosing cholangitis

Paul J. Marotta, Nicholas F La Russo, Russell H. Wiesner

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Primary sclerosing cholangitis (PSC) is a chronic, progressive cholestatic liver disease whose aetiopathogenesis is unknown. PSC is frequently associated with inflammatory bowel disease, in particular chronic ulcerative colitis, is most commonly observed in young males and is clinically characterized by fatigue, pruritus and jaundice. The diagnosis is supported by a cholestatic biochemical profile and histological abnormalities, and confirmed by visualization of an abnormal biliary tree. The natural history of the disease is currently being evaluated but is generally recognized to be slowly progressive, leading to complications of chronic cholestasis, portal hypertension and biliary cirrhosis. There is no specific medical treatment, and orthotopic liver transplantation remains the only definitive treatment for patients with end-stage PSC. A more rational approach to medical therapy will ensue upon a better understanding of the aetiopathogenesis of this disease.

Original languageEnglish (US)
Pages (from-to)781-800
Number of pages20
JournalBailliere's Clinical Gastroenterology
Volume11
Issue number4
DOIs
StatePublished - Dec 1997

Fingerprint

Sclerosing Cholangitis
Biliary Liver Cirrhosis
Cholestasis
Biliary Tract
Portal Hypertension
Pruritus
Jaundice
Ulcerative Colitis
Inflammatory Bowel Diseases
Liver Transplantation
Fatigue
Liver Diseases
Therapeutics

Keywords

  • Biliary tract
  • Cholangiocarcinoma
  • Cholangitis
  • Cholestasis
  • Chronic ulcerative colitis
  • Inflammatory bowel disease
  • Sclerosing cholangitis

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Sclerosing cholangitis. / Marotta, Paul J.; La Russo, Nicholas F; Wiesner, Russell H.

In: Bailliere's Clinical Gastroenterology, Vol. 11, No. 4, 12.1997, p. 781-800.

Research output: Contribution to journalArticle

Marotta, Paul J. ; La Russo, Nicholas F ; Wiesner, Russell H. / Sclerosing cholangitis. In: Bailliere's Clinical Gastroenterology. 1997 ; Vol. 11, No. 4. pp. 781-800.
@article{9872e699cc7447698ce3b795da657d11,
title = "Sclerosing cholangitis",
abstract = "Primary sclerosing cholangitis (PSC) is a chronic, progressive cholestatic liver disease whose aetiopathogenesis is unknown. PSC is frequently associated with inflammatory bowel disease, in particular chronic ulcerative colitis, is most commonly observed in young males and is clinically characterized by fatigue, pruritus and jaundice. The diagnosis is supported by a cholestatic biochemical profile and histological abnormalities, and confirmed by visualization of an abnormal biliary tree. The natural history of the disease is currently being evaluated but is generally recognized to be slowly progressive, leading to complications of chronic cholestasis, portal hypertension and biliary cirrhosis. There is no specific medical treatment, and orthotopic liver transplantation remains the only definitive treatment for patients with end-stage PSC. A more rational approach to medical therapy will ensue upon a better understanding of the aetiopathogenesis of this disease.",
keywords = "Biliary tract, Cholangiocarcinoma, Cholangitis, Cholestasis, Chronic ulcerative colitis, Inflammatory bowel disease, Sclerosing cholangitis",
author = "Marotta, {Paul J.} and {La Russo}, {Nicholas F} and Wiesner, {Russell H.}",
year = "1997",
month = "12",
doi = "10.1016/S0950-3528(97)90021-X",
language = "English (US)",
volume = "11",
pages = "781--800",
journal = "Bailliere's Clinical Gastroenterology",
issn = "0950-3528",
publisher = "Bailliere Tindall Ltd",
number = "4",

}

TY - JOUR

T1 - Sclerosing cholangitis

AU - Marotta, Paul J.

AU - La Russo, Nicholas F

AU - Wiesner, Russell H.

PY - 1997/12

Y1 - 1997/12

N2 - Primary sclerosing cholangitis (PSC) is a chronic, progressive cholestatic liver disease whose aetiopathogenesis is unknown. PSC is frequently associated with inflammatory bowel disease, in particular chronic ulcerative colitis, is most commonly observed in young males and is clinically characterized by fatigue, pruritus and jaundice. The diagnosis is supported by a cholestatic biochemical profile and histological abnormalities, and confirmed by visualization of an abnormal biliary tree. The natural history of the disease is currently being evaluated but is generally recognized to be slowly progressive, leading to complications of chronic cholestasis, portal hypertension and biliary cirrhosis. There is no specific medical treatment, and orthotopic liver transplantation remains the only definitive treatment for patients with end-stage PSC. A more rational approach to medical therapy will ensue upon a better understanding of the aetiopathogenesis of this disease.

AB - Primary sclerosing cholangitis (PSC) is a chronic, progressive cholestatic liver disease whose aetiopathogenesis is unknown. PSC is frequently associated with inflammatory bowel disease, in particular chronic ulcerative colitis, is most commonly observed in young males and is clinically characterized by fatigue, pruritus and jaundice. The diagnosis is supported by a cholestatic biochemical profile and histological abnormalities, and confirmed by visualization of an abnormal biliary tree. The natural history of the disease is currently being evaluated but is generally recognized to be slowly progressive, leading to complications of chronic cholestasis, portal hypertension and biliary cirrhosis. There is no specific medical treatment, and orthotopic liver transplantation remains the only definitive treatment for patients with end-stage PSC. A more rational approach to medical therapy will ensue upon a better understanding of the aetiopathogenesis of this disease.

KW - Biliary tract

KW - Cholangiocarcinoma

KW - Cholangitis

KW - Cholestasis

KW - Chronic ulcerative colitis

KW - Inflammatory bowel disease

KW - Sclerosing cholangitis

UR - http://www.scopus.com/inward/record.url?scp=0031471489&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031471489&partnerID=8YFLogxK

U2 - 10.1016/S0950-3528(97)90021-X

DO - 10.1016/S0950-3528(97)90021-X

M3 - Article

VL - 11

SP - 781

EP - 800

JO - Bailliere's Clinical Gastroenterology

JF - Bailliere's Clinical Gastroenterology

SN - 0950-3528

IS - 4

ER -